MET and non-small cell lung carcinoma: The over-expression of c-Met protein has been often detected in human cancers (including SCLC and NSCLC) (Bottaro et al., 1991; Liu et al., 2008), and abnormal function of c-Met signaling was observed in various solid and blood tumor cancers.